Dr. Lucía Ramírez Vega

Dr. Lucía Ramírez Vega is a distinguished medical oncologist at the Instituto Nacional de Cancerología (INCan) in Mexico City — Mexico's premier cancer reference center and one of the most respected oncology institutions in Latin America. With 17 years of clinical experience, she has dedicated her career to the comprehensive systemic treatment of solid tumors, with particular expertise in breast and gynecological cancers.

INCan is a public national health institution under Mexico's Secretaría de Salud and serves as the primary referral center for complex oncology cases from across Mexico and Central America. Dr. Ramírez Vega operates within a highly interdisciplinary environment, participating in tumor boards that bring together surgeons, radiation oncologists, pathologists, and radiologists to develop individualized treatment plans for each patient. Her approach emphasizes evidence-based medicine and the adoption of international oncology guidelines, adapted appropriately to the resources and clinical realities of the Mexican healthcare context.

Dr. Ramírez Vega is bilingual in Spanish and English, enabling her to collaborate directly with international colleagues and to serve patients from Central America, the United States border regions, and beyond who seek oncological care in Mexico City. She is a committed educator, serving as faculty in the Oncología Médica postgraduate training program at INCan and at the Universidad Nacional Autónoma de México (UNAM).

Her clinical philosophy is rooted in patient dignity and informed consent — she believes that patients facing a cancer diagnosis deserve honest, compassionate communication and access to all treatment options available. She works closely with palliative care teams to ensure that quality of life remains a central consideration throughout treatment.

Dr. Ramírez Vega completed her medical degree (Médico Cirujano) at the Universidad Nacional Autónoma de México (UNAM) Faculty of Medicine — Mexico's largest and most prestigious university medical program. She subsequently completed her specialty training in Internal Medicine (Medicina Interna) at the Hospital General de México.

She then pursued a three-year specialty in Oncología Médica (Medical Oncology) at the Instituto Nacional de Cancerología (INCan) — Mexico's national standard-setting body for oncology specialist training. During this fellowship, she received comprehensive training in chemotherapy administration, supportive oncology care, clinical trial methodology, and tumor board participation.

Dr. Ramírez Vega has undertaken continuing medical education at international institutions including the MD Anderson Cancer Center in Houston and the Institut Gustave Roussy in Paris, enriching her practice with cutting-edge international perspectives on breast and gynecological oncology. She holds specialist certification from the Consejo Mexicano de Oncología and is a full member of the European Society for Medical Oncology (ESMO).

Dr. Ramírez Vega's primary subspecialty focus is breast cancer, across all stages and biological subtypes. She manages hormone receptor-positive breast cancer with endocrine therapy and CDK4/6 inhibitors, HER2-positive breast cancer with trastuzumab-based regimens, and triple-negative breast cancer with chemotherapy and immunotherapy combinations. She has extensive experience in designing neoadjuvant chemotherapy protocols to downstage tumors before surgery and in adjuvant treatment planning to minimize recurrence risk.

In gynecological oncology, Dr. Ramírez Vega treats cervical cancer with chemotherapy and concurrent chemoradiation, ovarian cancer with platinum-based chemotherapy and PARP inhibitor maintenance therapy, and uterine cancer with systemic treatment. She also manages patients with metastatic colorectal cancer, lung adenocarcinoma, and gastric cancer.

Dr. Ramírez Vega is a strong proponent of molecular profiling for appropriate patient selection, advocating for immunohistochemistry and targeted sequencing to guide biomarker-driven therapy decisions within the resources available at INCan. She has particular clinical expertise in managing chemotherapy side effects and providing high-quality supportive oncology care to maintain patients' quality of life during treatment.

Dr. Ramírez Vega has published over 40 articles and case reports in national and international oncology journals including Gaceta Mexicana de Oncología, Revista de Investigación Clínica, and as a contributing author in collaborative Latin American oncology research published in the Journal of Clinical Oncology and Cancer. Her research focuses on clinical outcomes of breast cancer treatment at INCan, access to HER2-directed therapies in Mexico, and adaptation of international oncology guidelines to the Mexican health system context.

She participates as an investigator in multicentre clinical trials conducted through the Grupo Mexicano de Oncología (GMO) and has contributed patient data to international cooperative oncology studies coordinated through ASCO and ESMO. Her clinical practice emphasis means her research is deeply grounded in real-world outcomes and health equity — she has a particular interest in documenting disparities in cancer treatment access across Mexico's different regions and economic strata.

Dr. Ramírez Vega presents at the annual Congreso de la Sociedad Mexicana de Oncología and at the Latin American Cancer Congress. She is an active ESMO member and attends the ESMO Congress annually, staying current with the latest advances in systemic oncology therapy.

INCan is internationally known as Mexico's premier cancer center, and Dr. Ramírez Vega treats patients from Central America, the United States-Mexico border region, and other countries who seek high-quality oncology care in Mexico City at costs significantly lower than in the United States or Europe. She conducts consultations fluently in both Spanish and English.

For patients considering travel to Mexico City for oncological consultation or treatment, Dr. Ramírez Vega offers video telemedicine consultations to review existing pathology, imaging, and treatment records before an in-person visit is arranged. This allows patients to obtain an expert opinion on their diagnosis and proposed treatment plan, and to determine whether travelling to INCan for treatment is appropriate and necessary.

Dr. Ramírez Vega's team coordinates closely with INCan's administrative services to provide international patients with clear cost estimates for consultations, diagnostic workup, and planned treatment cycles. She provides detailed clinical summaries to patients' home physicians and supports safe handover of care for patients who return to their home countries during maintenance therapy.

Dr. Ramírez Vega has received recognition from the Sociedad Mexicana de Oncología for her contributions to oncology education and clinical training. She has been acknowledged by ESMO as a member who has contributed to improving cancer care standards in Latin America and has served as a faculty member at ESMO Latin America oncology training programs.

She holds specialist certification from the Consejo Mexicano de Oncología — Mexico's official body for oncology specialist credentialing — and is a full member of ESMO and ASCO. Dr. Ramírez Vega's commitment to cancer care in the public sector and to equity in oncology access has been recognized by her peers as a defining feature of her distinguished career at INCan.